Skip to main content
Erschienen in: Intensive Care Medicine 8/2005

01.08.2005 | Original

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

verfasst von: Rosa Reina, Elisa Estenssoro, Gabriela Sáenz, Héctor S. Canales, Romina Gonzalvo, Gabriela Vidal, Gustavo Martins, Andrea Das Neves, Oscar Santander, Carlos Ramos

Erschienen in: Intensive Care Medicine | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

Objective

To assess renal dysfunction and outcome in patients treated exclusively with colistin vs. other antibiotics.

Design and setting

Prospective cohort study in a mixed ICU in a university-affiliated hospital.

Patients

185 patients infected with Acinetobacter baumannii and Pseudomonas aeruginosa after an ICU stay longer than 48 h: 55 in the colistin group and 130 in the noncolistin group, similar in age, APACHE II, medical status, and SOFA score.

Measurements and results

We recorded data on epidemiology and severity of illness, site of infection, renal function before and after treatment, clinical cure, and mortality. Clinical cure was defined as simultaneous normalization of central temperature (≤38°), leukocyte count (≤10,000/mm3), and PaO2/FIO2 ratio (>187). Before treatment creatinine was 0.9±0.2 in the colistin group and 0.9±0.1 in the noncolistin group; after treatment the value was 1.0±0.3 in both groups. The most frequent infection was ventilator-associated pneumonia: 53% vs. 66% in colistin and noncolistin groups, respectively, Acinetobacter was the cause in 65% and 60% and Pseudomonas in 35% and 53%. In the noncolistin group 81% of patients were treated with carbapenems. Inadequate empirical antimicrobial treatment was more frequent in the colistin group (100% vs. 8%), but there were no differences in the frequency of clinical cure on day 6 of treatment (15% and 17%) or in mortality (29% and 24%).

Conclusions

Colistin appears to be as safe and as effective as other antimicrobials for treatment of sepsis caused by Acinetobacter and Pseudomonas in critically ill patients.
Literatur
1.
Zurück zum Zitat National Nosocomial Infections Surveillance System (1996) National nosocomial infections surveillance report, data summary from October 1986–April 1996. Am J Infect Control 24:380–388CrossRefPubMed National Nosocomial Infections Surveillance System (1996) National nosocomial infections surveillance report, data summary from October 1986–April 1996. Am J Infect Control 24:380–388CrossRefPubMed
2.
Zurück zum Zitat Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157:531–539PubMed Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157:531–539PubMed
3.
Zurück zum Zitat Leibovici L, Shraga I, Drucker M, Konigeberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386CrossRefPubMed Leibovici L, Shraga I, Drucker M, Konigeberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386CrossRefPubMed
4.
Zurück zum Zitat Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed
5.
Zurück zum Zitat Catchpole CR, Andrews JM, Brenwald N, Wise R (1997) A reassessment of the in vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 39:255–260CrossRefPubMed Catchpole CR, Andrews JM, Brenwald N, Wise R (1997) A reassessment of the in vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 39:255–260CrossRefPubMed
6.
Zurück zum Zitat Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EAG, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanii. Clin Infect Dis 28:1008–1011 Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EAG, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanii. Clin Infect Dis 28:1008–1011
7.
Zurück zum Zitat Evans ME, Feola DJ, Rapp RP (1999) Polymixyn B sulfate and colistin: old antibiotics for emerging multirresistant gram-negative bacteria. Ann Pharmacother 33:960–967CrossRefPubMed Evans ME, Feola DJ, Rapp RP (1999) Polymixyn B sulfate and colistin: old antibiotics for emerging multirresistant gram-negative bacteria. Ann Pharmacother 33:960–967CrossRefPubMed
8.
Zurück zum Zitat Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez J, Barrero-Almodóvar E, García-Garmendia JL, Bernabeu-Witell M, Gallego-Lara SL, Madrazo-Osuna J (2003) Treatment of multidrug-resistant Acinetobacter baumanii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with Imipenem-susceptible VAP. Clin Infect Dis 36:1111–1118CrossRefPubMed Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez J, Barrero-Almodóvar E, García-Garmendia JL, Bernabeu-Witell M, Gallego-Lara SL, Madrazo-Osuna J (2003) Treatment of multidrug-resistant Acinetobacter baumanii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with Imipenem-susceptible VAP. Clin Infect Dis 36:1111–1118CrossRefPubMed
9.
Zurück zum Zitat Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L (2003) Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7:R78–R83CrossRefPubMed Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L (2003) Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7:R78–R83CrossRefPubMed
10.
Zurück zum Zitat Horton J, Pankey GA (1982) Polymyxin B, colistin, and sodium colistimethate. Med Clin North Am 66:135–142PubMed Horton J, Pankey GA (1982) Polymyxin B, colistin, and sodium colistimethate. Med Clin North Am 66:135–142PubMed
11.
Zurück zum Zitat Kunin CM, Bugg A (1971) Binding of polimyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis 124:394–400PubMed Kunin CM, Bugg A (1971) Binding of polimyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis 124:394–400PubMed
12.
Zurück zum Zitat Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polimixin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183–190CrossRefPubMed Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polimixin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183–190CrossRefPubMed
13.
Zurück zum Zitat Koch-Weser J, Sidel VW, Federman EB (1970) Adverse effects of sodium colisimethate: manifestations and specific rates during 317 courses of therapy. Ann Intern Med 72:857–868PubMed Koch-Weser J, Sidel VW, Federman EB (1970) Adverse effects of sodium colisimethate: manifestations and specific rates during 317 courses of therapy. Ann Intern Med 72:857–868PubMed
14.
Zurück zum Zitat Wolinsky E, Hines JD (1972) Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. N Engl J Med 266:759–762 Wolinsky E, Hines JD (1972) Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. N Engl J Med 266:759–762
15.
Zurück zum Zitat Reina R, Estenssoro E, Saenz G, Canales H, Gonzalvo R, Vidal G, Martins G, DasNeves A, Santander O, Ramos C (2004) Safety of IV colistin use in severe ICU infections. Am J Respir Crit Care Med 169:A127 Reina R, Estenssoro E, Saenz G, Canales H, Gonzalvo R, Vidal G, Martins G, DasNeves A, Santander O, Ramos C (2004) Safety of IV colistin use in severe ICU infections. Am J Respir Crit Care Med 169:A127
16.
Zurück zum Zitat Troché G, Moine P (1997) Is the duration of mechanical ventilation predictable? Chest 112:745–751PubMed Troché G, Moine P (1997) Is the duration of mechanical ventilation predictable? Chest 112:745–751PubMed
17.
Zurück zum Zitat McCabe WR, Jackson GG (1962) Gram-negative bacteriemia. I. Etiology and ecology. Arch Intern Med 110:845–847 McCabe WR, Jackson GG (1962) Gram-negative bacteriemia. I. Etiology and ecology. Arch Intern Med 110:845–847
18.
Zurück zum Zitat Vincent JL, De Mendoça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ disfunction/failure in intensive care unit: results of a multicentre, prospective study. Crit Care Med 26:1793–1800 Vincent JL, De Mendoça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ disfunction/failure in intensive care unit: results of a multicentre, prospective study. Crit Care Med 26:1793–1800
19.
Zurück zum Zitat Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections (1996) In: Olmsted RN (ed) Infection control and applied epidemiology: principles and practice. Mosby, St. Louis, pp A1–A20 Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections (1996) In: Olmsted RN (ed) Infection control and applied epidemiology: principles and practice. Mosby, St. Louis, pp A1–A20
20.
Zurück zum Zitat American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis, multiple organ failure, guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655PubMed American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis, multiple organ failure, guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655PubMed
21.
Zurück zum Zitat Kollef MH, Silver P, Murphy D, Trovillion E (1995) The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108:1655–1662PubMed Kollef MH, Silver P, Murphy D, Trovillion E (1995) The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108:1655–1662PubMed
22.
Zurück zum Zitat Meduri GU, Chastre J (1992) The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 102:557S-564SPubMed Meduri GU, Chastre J (1992) The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 102:557S-564SPubMed
23.
Zurück zum Zitat Kollef MH, Bock KR, Richards RD, Hearns ML (1995) The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 122:743–748PubMed Kollef MH, Bock KR, Richards RD, Hearns ML (1995) The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 122:743–748PubMed
24.
Zurück zum Zitat Torres A, el-Ebiary M, Padro L, González J, de la Bellacasa JP, Ramírez J, Xaubet A, Ferrer M, Rodríguez-Roisin R (1994) Validation of different techniques for the diagnosis of ventilator-associated pneumonia: comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 149:324–331PubMed Torres A, el-Ebiary M, Padro L, González J, de la Bellacasa JP, Ramírez J, Xaubet A, Ferrer M, Rodríguez-Roisin R (1994) Validation of different techniques for the diagnosis of ventilator-associated pneumonia: comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 149:324–331PubMed
25.
Zurück zum Zitat Crouch BS, Wunderink RG, Jones CB, Leeper KV Jr (1996) Ventilator-associated pneumonia due to Pseudomona aeruginosa Chest 109:1119–1120 Crouch BS, Wunderink RG, Jones CB, Leeper KV Jr (1996) Ventilator-associated pneumonia due to Pseudomona aeruginosa Chest 109:1119–1120
26.
Zurück zum Zitat Mermel LA, Farr BM, Sheretz RJ, Raad II, O’Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32:1249–1272 Mermel LA, Farr BM, Sheretz RJ, Raad II, O’Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32:1249–1272
27.
Zurück zum Zitat Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, Swartz MN (1993) Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328:21–28CrossRefPubMed Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, Swartz MN (1993) Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328:21–28CrossRefPubMed
28.
Zurück zum Zitat Gantzs NM, Tkatch LS (1999) Nosocomial central nervous system infections. In: Mayhall CG (ed) Hospital epidemiology and infection control. Lippincott Williams & Wilkins, Philadelphia, pp 301–322 Gantzs NM, Tkatch LS (1999) Nosocomial central nervous system infections. In: Mayhall CG (ed) Hospital epidemiology and infection control. Lippincott Williams & Wilkins, Philadelphia, pp 301–322
29.
Zurück zum Zitat Hasbun R, Abrahamas J, Jekel J, Quagliarello VJ (2001) Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 345:1727–1733CrossRefPubMed Hasbun R, Abrahamas J, Jekel J, Quagliarello VJ (2001) Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 345:1727–1733CrossRefPubMed
30.
Zurück zum Zitat Brun Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 274:968–974CrossRefPubMed Brun Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 274:968–974CrossRefPubMed
31.
Zurück zum Zitat Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371–1375PubMed Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371–1375PubMed
32.
Zurück zum Zitat Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 132:621–630PubMed Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 132:621–630PubMed
33.
Zurück zum Zitat Rello J, Mariscal D, March F, Jubert P, Sanchez G, Valles J, Coll P (1998) Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients relapse or reinfection? Am J Respir Crit Care Med 157:912–916PubMed Rello J, Mariscal D, March F, Jubert P, Sanchez G, Valles J, Coll P (1998) Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients relapse or reinfection? Am J Respir Crit Care Med 157:912–916PubMed
34.
Zurück zum Zitat Liano F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50:811–818PubMed Liano F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50:811–818PubMed
35.
Zurück zum Zitat Monarch Pharmaceuticals (2001) Coly-mycin M parenteral (package insert). Monarch Pharmaceuticals, Bristol Monarch Pharmaceuticals (2001) Coly-mycin M parenteral (package insert). Monarch Pharmaceuticals, Bristol
36.
Zurück zum Zitat Vincent JL, Bihari DJ, Suter PM, Bruining HA, Nicholas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644CrossRefPubMed Vincent JL, Bihari DJ, Suter PM, Bruining HA, Nicholas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644CrossRefPubMed
37.
Zurück zum Zitat Richards MJ, Edwards JR, Culver DH et al. (1999) Nosocomial Infections in medical intensive care in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27:887–892CrossRefPubMed Richards MJ, Edwards JR, Culver DH et al. (1999) Nosocomial Infections in medical intensive care in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27:887–892CrossRefPubMed
38.
Zurück zum Zitat Quinn JP: Clinical problems posed by multiresistant nonfermenting gram-negative pathogens (1998) Clin Infect Dis 27 [Suppl 1]:S117–S124 Quinn JP: Clinical problems posed by multiresistant nonfermenting gram-negative pathogens (1998) Clin Infect Dis 27 [Suppl 1]:S117–S124
39.
Zurück zum Zitat Appleman MD, Belzberg H, Citron DM, Heseltine PN, Yellin AE, Murray J, Berne TV (2000) In vitro activities of nontraditional antimicrobials against multirresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob Agents Chemother 44:1035–1040CrossRefPubMed Appleman MD, Belzberg H, Citron DM, Heseltine PN, Yellin AE, Murray J, Berne TV (2000) In vitro activities of nontraditional antimicrobials against multirresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob Agents Chemother 44:1035–1040CrossRefPubMed
40.
Zurück zum Zitat Li J, Turnidge J, Milne R, Nation RL, Coulthard K (2001) In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 45:781–785CrossRefPubMed Li J, Turnidge J, Milne R, Nation RL, Coulthard K (2001) In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 45:781–785CrossRefPubMed
41.
Zurück zum Zitat Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC (1999) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685 Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC (1999) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685
42.
Zurück zum Zitat Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed
43.
Zurück zum Zitat Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155CrossRefPubMed Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155CrossRefPubMed
44.
Zurück zum Zitat Clec’h C, Timsit JF, De Lassence A, Azoulay E, Alberti C, Garrouste Orgeas M, Mourvilier B, Troche G, Tafflet M, Tuil O, Cohen Y (2004) Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence on disease severity. Intensive Care Med 30:1327–1333PubMed Clec’h C, Timsit JF, De Lassence A, Azoulay E, Alberti C, Garrouste Orgeas M, Mourvilier B, Troche G, Tafflet M, Tuil O, Cohen Y (2004) Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence on disease severity. Intensive Care Med 30:1327–1333PubMed
45.
Zurück zum Zitat Kalb TH, Lorin S (2002) Infection in the chronically critically ill: unique risk profile in a newly defined population. Crit Care Clin 18:529–552CrossRefPubMed Kalb TH, Lorin S (2002) Infection in the chronically critically ill: unique risk profile in a newly defined population. Crit Care Clin 18:529–552CrossRefPubMed
46.
Zurück zum Zitat Hughes M, McKirdy FN, Norrie J, Grant IS (2001) Outcomes of long-stay intensive care patients. Intensive Care Med 27:779–782CrossRefPubMed Hughes M, McKirdy FN, Norrie J, Grant IS (2001) Outcomes of long-stay intensive care patients. Intensive Care Med 27:779–782CrossRefPubMed
47.
Zurück zum Zitat Estenssoro E, González F, Laffaire E, Canales H, Sáenz G, Reina R, Dubin A (2005) Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest 127:598–603CrossRefPubMed Estenssoro E, González F, Laffaire E, Canales H, Sáenz G, Reina R, Dubin A (2005) Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest 127:598–603CrossRefPubMed
48.
Zurück zum Zitat Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW (2003) Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37:745–751CrossRefPubMed Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW (2003) Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37:745–751CrossRefPubMed
49.
Zurück zum Zitat Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR (1989) Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87:540–546PubMed Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR (1989) Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87:540–546PubMed
50.
Zurück zum Zitat Garnacho J, Sole-Violan J, Sa-Borges M, Díaz E, Rello J (2003) Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study. Crit Care Med 31:2478–2482CrossRefPubMed Garnacho J, Sole-Violan J, Sa-Borges M, Díaz E, Rello J (2003) Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study. Crit Care Med 31:2478–2482CrossRefPubMed
51.
Zurück zum Zitat Montero A, Corbella X, Ariza J (2003) Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia. Crit Care Med 31:257–259 Montero A, Corbella X, Ariza J (2003) Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia. Crit Care Med 31:257–259
52.
Zurück zum Zitat Blot S, Vandewoude K, Colardyn F (2003) Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 29:471–475PubMed Blot S, Vandewoude K, Colardyn F (2003) Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 29:471–475PubMed
53.
Zurück zum Zitat Rello J, Díaz E (2003) Acinetobacter baumannii: a threat for the ICU? Intensive Care Med 29:350–351PubMed Rello J, Díaz E (2003) Acinetobacter baumannii: a threat for the ICU? Intensive Care Med 29:350–351PubMed
54.
Zurück zum Zitat Reed MD, Stern RC, O’Riordan MA, Blumer JL (2001) The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 41:645–654CrossRefPubMed Reed MD, Stern RC, O’Riordan MA, Blumer JL (2001) The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 41:645–654CrossRefPubMed
55.
Zurück zum Zitat Montravers P, Fagon JY, Chastre J, Lesco M, Dombret MC, Trouillet JL, Gibert C (1993) Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147:38–44PubMed Montravers P, Fagon JY, Chastre J, Lesco M, Dombret MC, Trouillet JL, Gibert C (1993) Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147:38–44PubMed
56.
Zurück zum Zitat Ioanas M, Ewig S, Torres A (2003) Treatment failures in patients with ventilator-associated pneumonia. Infect Dis Clin North Am 17:753–771CrossRefPubMed Ioanas M, Ewig S, Torres A (2003) Treatment failures in patients with ventilator-associated pneumonia. Infect Dis Clin North Am 17:753–771CrossRefPubMed
57.
Zurück zum Zitat Browner RS, Newman TB, Cummings SR, Hulley SB (2001) Estimating sample size and power: the nitty-gritty. In: Hulley S, Cummings SR, Browner RS, Grady D, Hearst N, Newman TB (eds) Designing clinical research. An epidemiological approach, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 65–91 Browner RS, Newman TB, Cummings SR, Hulley SB (2001) Estimating sample size and power: the nitty-gritty. In: Hulley S, Cummings SR, Browner RS, Grady D, Hearst N, Newman TB (eds) Designing clinical research. An epidemiological approach, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 65–91
Metadaten
Titel
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study
verfasst von
Rosa Reina
Elisa Estenssoro
Gabriela Sáenz
Héctor S. Canales
Romina Gonzalvo
Gabriela Vidal
Gustavo Martins
Andrea Das Neves
Oscar Santander
Carlos Ramos
Publikationsdatum
01.08.2005
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 8/2005
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-2691-4

Weitere Artikel der Ausgabe 8/2005

Intensive Care Medicine 8/2005 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.